|
|
|
| Name of Company | Dishman Pharmaceuticals & Chemicals Ltd |
| BSE Code | 532526 |
| NSE Code | DISHMAN |
| ICICI Code | |
| Established | 1983 |
| My Take | So-So |
| Headquarters | Ahmedabad |
| Promoters | |
| Story | Facilities in Europe, India and China. Listed in 2004. Acquisitions brought CRAMS CARBOGEN AMCIS (Swiss) and IO3S (Swiss) into Dishman. |
| Sector | Pharma |
| Sub-sector | CRAMS, APIs |
| Website | |
| Positives | Good NPMs at 16-19%. Shows 600 Cr reserves (which almost 45% of current market cap). Regular dividends, yields around 0.8% at current prices. |
| Negatives | 434 Cr of debt in FY10. Revenue guidance revised to 10%. FY09 revenue and profit was bigger than FY10 numbers. |
| Peers | Shasun, Divi's lab, Nicholas Piramal |
| News | |
| Price @ blogged | 169(12-Nov-10) |
| Cost of company | 1361 Cr market cap for a 71 Cr FY NP makes it less than 20 times. 434 Cr debt and lower revenue visibility makes it costly even with high NPM's. |
Nov 13, 2010
Dishman Pharmaceuticals & Chemicals Ltd - 532526
Subscribe to:
Post Comments (Atom)
LinkWithin
No comments:
Post a Comment